1,081
Views
3
CrossRef citations to date
0
Altmetric
Technical Paper

Integrating site-specific dispersion modeling into life cycle assessment, with a focus on inhalation risks in chemical production

ORCID Icon &
Pages 1224-1238 | Received 03 Apr 2018, Accepted 27 Jun 2018, Published online: 01 Oct 2018

Figures & data

Table 1. Existing LCIA methods/models for assessing human health impact.

Table 2. Classification of unit processes (based on ACC LCI; American Chemistry Council Citation2011) .

Figure 1. The system boundary of cradle-to-gate MDI production (modified from American Chemistry Council Citation2011).

Figure 1. The system boundary of cradle-to-gate MDI production (modified from American Chemistry Council Citation2011).

Table 3. Unit processes and site-specific modeling/average stack parameters (EPA Citation1999a) .

Figure 2. Census tract–level inhalation risks of site-specific unit processes (left: cancer risk; right: noncancer HI).

Figure 2. Census tract–level inhalation risks of site-specific unit processes (left: cancer risk; right: noncancer HI).

Figure 3. County-level average inhalation risks of site-specific unit processes (left: cancer risk; right: noncancer hazard index).

Figure 3. County-level average inhalation risks of site-specific unit processes (left: cancer risk; right: noncancer hazard index).

Figure 4. Distribution of inhalation risks associated with site-specific unit processes at the county level (left: cancer risk; right: noncancer hazard index).

Figure 4. Distribution of inhalation risks associated with site-specific unit processes at the county level (left: cancer risk; right: noncancer hazard index).

Table 4. Production capacities of chemical plants in relatively high risk areas.

Figure 5. Site-specific plant locations and high cancer risk areas.

Figure 5. Site-specific plant locations and high cancer risk areas.

Figure 6. Site-specific plant locations and high noncancer hazard index areas.

Figure 6. Site-specific plant locations and high noncancer hazard index areas.

Table 5. Inhalation risks of unit processes without exact location (HAPs emitted to the continental air compartment).

Figure 7. Inhalation risks by HAPs for non-site-specific unit processes.

Figure 7. Inhalation risks by HAPs for non-site-specific unit processes.

Table 6. County-level inhalation risk statistics (AERMOD).

Table 7. Inhalation risks of site-specific unit processes (if using USEtox) (assuming that HAPs were emitted to the urban air compartment).

Table 8. Inhalation risks of non-site-specific unit processes (assuming that HAPs were emitted to the urban air compartment).

Figure 8. Relative contributions of unit processes to inhalation risks.

Figure 8. Relative contributions of unit processes to inhalation risks.

Table 9. Mass distributions of HAPs in different environmental compartments.

Supplemental material

Supplemental Material

Download MS Word (45.2 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.